KBI Biopharma

6 min read

Beyond the Count: Why Particle Forensics Matters More Than Ever in Biologics Development

3 min read

Cutting Time, Cost, and Material for Viral Clearance Studies: A Proven Dual Virus Spike Approach

1 min read

Reducing CMC Risk Through TIME with KBI's Proven Analytical & Formulation Expertise

3 min read

Choosing The Ideal CDMO Partner For Cell Line Development

1 min read

Characterization & Control Strategy for an ADC

1 min read

Breaking Barriers: Combining Cell Line Development Innovation with Improved Process Development Workflows to Streamline Path to FIH

9 min read

Rapid Timeline to Tox Starting with KBI Biopharma's SUREtechnology Platform™, Powered by Selexis®

1 min read

Driving CDMO Efficiency - The Power of Flexible Platforms and Digital Data Access

3 min read

Adeno-Associated Virus-Mediated Gene Therapy: Analytical Advancements in Characterizing Size Distribution using SV-AUC and Multi-Wavelength Analysis for Accurate Identification of Resolved Species

Poster: Comprehensive Size Distribution Analysis of Adeno-Associated Virus Fill States